Overview
Vorwarts Pharma manufactures dietary supplements in line with international standards and works with leading European producers. Its portfolio includes Betargin, Mamalac, Artizhel, Epiwell, Lorekt and Flomma, covering support for detox, digestion, liver function, immunity, mucous membranes and sleep. The company also handles marketing, distribution and international activity, and produces branded products in GMP-certified plants.
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 432 days for 2020).
- 202510/06/2026
- 202416/04/2025
- 202310/05/2024
- 202229/05/2023
- 202121/12/2022
- 202021/12/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The site is available in: Polish, English and Ukrainian.
- vorwartspharma.plSklep internetowy firmy farmaceutycznej Vorwarts PharmaWooCommerceWordPress 6.8Google AnalyticsGoogle Tag ManagerRRank MathCloudflare
Trademarks
The company holds 12 active trademarks registered with the Polish Patent Office. 6 applications are pending. 3 marks have expired or were not registered. The first mark was filed in 2020.
| Mark | Protected until | |
|---|---|---|
| REVITALOSE | Jul 2, 2034 | |
| FLomma | May 16, 2034 | |
| evisio | May 16, 2034 | |
| DŻILLA (word) | Mar 26, 2034 | |
| EPIWELL (word) | Mar 20, 2034 |
Authorized Representatives
Manner of representation
If the management board is a multi-member management board, joint action by two members of the management board is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mariia Boiko | 10 | $135.06 | 10% |
Sergii Boiko age 51 | 90 | $1,215.56 | 90% |
Sergii Boiko and Mariia Boiko hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-04-07.
88 1020 1332 0000 1002 1095 0493
78 1020 1332 0000 1402 1095 0477
83 1020 1332 0000 1202 1095 0485
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medifar sp. z o.o. | $1,749,974.76 | medifar.pl | ||
| Pharmavene sp. z o.o. | $783,187.61 | pharmavene.com | ||
| Hauster sp. z o.o. sp. k. | $577,912.26 | hauster.pl | ||
| Nexon Pharma sp. z o.o. | $574,250.90 | nexonpharma.pl | ||
| KE Pharma Spółka z Ograniczoną Odpowiedzialością sp. z o.o. | $499,386.90 | kepharma.pl | ||
| Cergopharma sp. z o.o. | $408,133.66 | cergopharma.pl | ||
| PM Pharma sp. z o.o. | $317,113.06 | zumax.me | ||
| A&M Invest sp. z o.o. | $228,914.93 | ampsuplementy.pl | ||
| Kosma Pharma Group sp. z o.o. | $198,964.09 | lpc37.pl | ||
| Holistic Poland sp. z o.o. | $88,773.39 | holistic-polska.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-06-16 | PKD change (Added: 47.91.Z) | |
| 2020-11-23 | Address change (Ul. Łąkowa 9/46, 15-017, Białystok → Ul. Żurawia 43/304, 00-680, Warszawa) | |
| 2020-11-23 | PKD change (Added: 8 codes) | |
| 2018-02-21 | Entered in the register |
FAQ
Last updated: 2026-07-09